
Rx Rundown: GSK, Novo Norisk, Recursion and more
Deals: GSK pledged $49 million up front and up to $2.6 billion in milestones to South Korea’s ABL Biopharma. Novo Nordisk invested $1.09 billion in Brazil to scale up the production of its GLP-1 drugs Sea Pharmaceuticals selected Inotiv for pre-clinical …